Eiji Takeuchi (E Takeuchi)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 18

Top Venues

Thoracic cancer

Cancer immunology, immunotherapy : CII

Cancer reports (Hoboken, N.J.)

Medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Eiji Takeuchi, Kensuke Kondo, Yoshio Okano, Seiya Ichihara, Michihiro Kunishige, Naoki Kadota, Hisanori Machida, Nobuo Hatakeyama, Keishi Naruse, Hirokazu Ogino, Hiroshi Nokihara, Tsutomu Shinohara, Yasuhiko Nishioka
Pretreatment eosinophil counts as a predictive biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors. Thoracic cancer (2023)
Eiji Takeuchi, Hirokazu Ogino, Kensuke Kondo, Yoshio Okano, Seiya Ichihara, Michihiro Kunishige, Naoki Kadota, Hisanori Machida, Nobuo Hatakeyama, Keishi Naruse, Hiroshi Nokihara, Tsutomu Shinohara, Yasuhiko Nishioka
An increased relative eosinophil count as a predictive dynamic biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors. Thoracic cancer (2023)
Michihiro Kunishige, Eiji Takeuchi
Miliary brain metastases from lung adenocarcinoma with EGFR (L858R) and CTNNB1 mutations. Thoracic cancer (2023)
Yohei Yabuki, Masaki Hanibuchi, Eiji Takeuchi, Takashi Haku, Takanori Kanematsu, Naoki Nishimura, Yuko Toyoda, Atsushi Mitsuhashi, Kenji Otsuka, Seidai Sato, Hisatsugu Goto, Hiroto Yoneda, Hirokazu Ogino, Hiroshi Nokihara, Shinohara Tsutomu, Yasuhiko Nishioka
A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non-small cell lung cancer. Thoracic cancer (2023)
Junki Terada, Yuko Toyoda, Eiji Takeuchi, Nobuyuki Tanida, Satoshi Ito, Kenji Yorita, Hisashi Matsuoka, Hiroki Bando, Yutaka Morita, Yuri Okamoto, Tsutomu Shinohara
Surgical resection combined with perioperative chemotherapy for a patient with locally recurrent, previously stage IV thymic small-cell carcinoma: A case report. Thoracic cancer 13 (23) (2022)
Michihiro Kunishige, Seiya Ichihara, Naoki Kadota, Yoshio Okano, Hisanori Machida, Nobuo Hatakeyama, Keishi Naruse, Tsutomu Shinohara, Eiji Takeuchi
Non-small cell lung cancer with EGFR (L858R and E709X) and CNNB1 mutations responded to afatinib. Thoracic cancer 14 (4) (2022)
Michihiro Kunishige, Seiya Ichihara, Naoki Kadota, Yoshio Okano, Hisanori Machida, Nobuo Hatakeyama, Keishi Naruse, Tsutomu Shinohara, Eiji Takeuchi
Non-small cell lung cancer with EGFR (L858R and E709X) and CNNB1 mutations responded to afatinib. Thoracic cancer 14 (4) (2022)
Seiya Ichihara, Michihiro Kunishige, Naoki Kadota, Yoshio Okano, Hisanori Machida, Nobuo Hatakeyama, Keishi Naruse, Tsutomu Shinohara, Eiji Takeuchi
Late-onset acute type 1 diabetes mellitus 7 months after discontinuation of pembrolizumab against lung cancer. Thoracic cancer (2022)
Yutaka Morita, Yoshihiro Kondo, Eiji Takeuchi
Pulmonary mycobacteriosis caused by Mycobacterium peregrinum: A case report. Medicine 101 (6) (2022)
N Kadota, N Nakahira, M Miyauchi, K Naruse, Eiji Takeuchi, Tsutomu Shinohara
Usefulness of bronchoalveolar lavage (BAL) in the diagnosis of pulmonary alveolar proteinosis. QJM : monthly journal of the Association of Physicians 115 (11) (2022)
Michihiro Kunishige, Seiya Ichihara, Naoki Kadota, Yoshio Okano, Hisanori Machida, Nobuo Hatakeyama, Keishi Naruse, Tsutomu Shinohara, Eiji Takeuchi
Non-small cell lung cancer with EGFR (L858R and E709X) and CNNB1 mutations responded to afatinib. Thoracic cancer (2022)
Michihiro Kunishige, Seiya Ichihara, Naoki Kadota, Yoshio Okano, Hisanori Machida, Nobuo Hatakeyama, Keishi Naruse, Tsutomu Shinohara, Eiji Takeuchi
Non-small cell lung cancer with EGFR (L858R and E709X) and CNNB1 mutations responded to afatinib. Thoracic cancer 14 (4) (2022)
Yoshihiro Kondo, Michihiro Kunishige, Naoki Kadota, Yoshio Okano, Hisanori Machida, Nobuo Hatakeyama, Keishi Naruse, Tsutomu Shinohara, Eiji Takeuchi
A single dose of pembrolizumab treatment causing a profound and durable response in lung cancer. Thoracic cancer 13 (4) (2022)
Eiji Takeuchi, Yoshio Okano, Hisanori Machida, Katsuhiro Atagi, Yoshihiro Kondou, Naoki Kadota, Nobuo Hatakeyama, Keishi Naruse, Tsutomu Shinohara
Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion. Cancer immunology, immunotherapy : CII (2021)
Naoki Kadota, Nobuo Hatakeyama, Hiroyuki Hino, Michihiro Kunishige, Yoshihiro Kondo, Yoshio Okano, Hisanori Machida, Keishi Naruse, Tsutomu Shinohara, Shoji Sakiyama, Fumitaka Ogushi, Eiji Takeuchi
Complete and durable response of pulmonary large-cell neuroendocrine carcinoma to pembrolizumab. Cancer reports (Hoboken, N.J.) (2021)
Yoshio Okano, Michihiro Kunishige, Yoshihiro Kondo, Naoki Kadota, Atsushi Morishita, Keishi Naruse, Hisanori Machida, Nobuo Hatakeyama, Hiroyuki Hino, Tsutomu Shinohara, Shoji Sakiyama, Eiji Takeuchi
Dramatic response to immunochemotherapy followed by salvage surgery in an elderly lung cancer patient. Thoracic cancer 13 (3) (2021)
Eiji Takeuchi, Naoki Takahashi, Shun Morizumi, Hiroyuki Tamiya, Hisashi Matsuoka, Naoto Kuroda, Kenji Yorita
Interleukin-5-producing malignant pleural mesothelioma with eosinophilic pleural effusion. Thoracic cancer 11 (10) (2020)
Eiji Takeuchi, Yuri Okamoto, Naoki Takahashi, Shun Morizumi, Yuko Toyoda, Naoto Kuroda, Kenji Yorita
Complete response of squamous cell carcinoma of the lung following treatment with pembrolizumab in an elderly patient: A case report. Thoracic cancer 12 (2) (2020)

Eiji Takeuchi.css-eqlu8i{font-size:small;padding-left:4px;} (E Takeuchi)

Publication Activity (10 Years)

Top Topics

Top Venues

Eiji Takeuchi (E Takeuchi)